SCHEMBL7301415

SCHEMBL7301415

NN1C(=O)CC=CN1c1ccccc1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 4/20 0.37
KMT2A Q03164 4/20 0.37
ALDH1A1 P00352 4/20 0.37
NPC1 O15118 1/20 0.36
RAB9A P51151 1/20 0.36
HPGD P15428 1/20 0.34
GAA P10253 5/20 0.33
MAPT P10636 2/20 0.33
SMN1; SMN2 Q16637 2/20 0.33
MGLL Q99685 1/20 0.33
KDM4E B2RXH2 1/20 0.33
CYP1A2 P05177 1/20 0.33
CHRM2 P08172 1/20 0.33
CYP3A4 P08684 1/20 0.33
CHRM1 P11229 1/20 0.33
TSHR P16473 1/20 0.33
PTGS1 P23219 1/20 0.33
DRD3 P35462 1/20 0.33
TDP1 Q9NUW8 1/20 0.33
GFER P55789 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16291450 0.74 MEN1 (0.41) MEN1KMT2AALDH1A1NPC1RAB9A
SCHEMBL7871541 0.73 ALDH1A1 (0.34) MEN1KMT2AALDH1A1NPC1RAB9A
SCHEMBL9645295 0.72 GSK3A (0.40) ALDH1A1GAAMGLLGSK3AGSK3B
SCHEMBL9645259 0.72 NPC1 (0.45) MEN1KMT2AALDH1A1NPC1RAB9A
SCHEMBL9645416 0.68 MEN1 (0.40) MEN1KMT2AALDH1A1GAAKDM4E
SCHEMBL9645868 0.66 APP (0.40) ALDH1A1TSHRPKM
SCHEMBL9645288 0.65 GAA (0.44) ALDH1A1GAASMN1; SMN2KDM4ECYP1A2
SCHEMBL22357884 0.64 KMT2A (0.48) MEN1KMT2AALDH1A1NPC1RAB9A
SCHEMBL5170272 0.63 NPC1 (0.38) MEN1KMT2AALDH1A1NPC1RAB9A
SCHEMBL8526316 0.63 MGLL (0.59) MEN1KMT2AALDH1A1HPGDGAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0042513-B1 DIHYDROPYRIDAZINONES, PROCESSES FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THESE COMPOUNDS BASF Aktiengesellschaft (DE) 1984-08-08 EP claimed
EP-0042513-A1 Dihydropyridazinones, processes for their preparation and pharmaceutical compositions containing these compounds BASF Aktiengesellschaft (DE) 1981-12-30 EP claimed
US-5151420-A Cardiovascular disorders ORION CORPORATION/ORION PHARMACEUTICA (FI) 1992-09-29 US disclosed
EP-0359439-A1 Substituted pyridazinones ORION-YHTYMÄ OY (FI) 1990-03-21 EP disclosed
EP-0042513-B1 DIHYDROPYRIDAZINONES, PROCESSES FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THESE COMPOUNDS BASF Aktiengesellschaft (DE) 1984-08-08 EP disclosed
US-4415571-A HYPOTENSIVE AGENTS; THROMBOSIS; ANTICOAGULANTS; CARDIOVASCULAR DISORDDERS BASF AKTIENGESELLSCHAFT (DE) 1983-11-15 US disclosed
EP-0042513-A1 Dihydropyridazinones, processes for their preparation and pharmaceutical compositions containing these compounds BASF Aktiengesellschaft (DE) 1981-12-30 EP disclosed